Abstract: Aldose reductase inhibitors of the formula ##STR1## wherein R.sup.1 and R.sup.2 each is lower alkyl, or a therapeutically acceptable salt thereof with an organic or inorganic base, are useful for treating diabetic complications.
Type:
Grant
Filed:
November 13, 1981
Date of Patent:
July 5, 1983
Assignee:
Ayerst, McKenna & Harrison Inc.
Inventors:
Francesco Bellini, Kazimir Sestanj, Leslie G. Humber